Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Impact of GLP-1 on Obesity Glucagon-like peptide-1 (GLP-1) receptor agonists, initially designed for type 2 diabetes (T2D), have emerged as a revolutionary treatment for obesity owing to their significant impact on weight reduction and metabolic control
PMID 15528186
If these studies do evidence these wider benefits, the case for wider public coverage of OMs will be greatly strengthened
Receptor-focused refinment maps for conformer 1 (i) and conformer 2 (n)
GengXZouYHLiJHLiSPQiRLYuHLet al
US$ 22.22
US$ 25.24
US$ 26.95
US$ 21.68
US$ 24.17
US$ 29.59
